Synergistic Induction of Apoptosis by Quercetin and Curcumin in Chronic Myeloid Leukemia (K562) Cells: II. Signal Transduction Pathways Involved

References

• Huang C-Y, Ju D-T, Chang C-F, Reddy PM, Velmurugan BK. A review on the effects of current chemotherapy drugs and natural agents in treating non–small cell lung cancer. Biomedicine (Taipei). 2017;7(4):23. doi:10.1051/bmdcn/2017070423
   PubMedGoogle Scholar
• Flis S, Chojnacki T. Chronic myelogenous leukemia, a still unsolved problem: pitfalls and new therapeutic possibilities. Drug Des Devel Ther. 2019;13:825–43. doi:10.2147/DDDT.S191303
   PubMed Web of Science ®Google Scholar
• Li J, Halfter K, Zhang M, Saad C, Xu K, Bauer B, Huang Y, Shi L, Mansmann UR. Computational analysis of receptor tyrosine kinase inhibitors and cancer metabolism: implications for treatment and discovery of potential therapeutic signatures. BMC Cancer. 2019;19(1):600. doi:10.1186/s12885-019-5804-0
   PubMed Web of Science ®Google Scholar
• Güran M, Şanlıtürk G, Kerküklü NR, Altundağ EM, Yalçın AS. Combined effects of quercetin and curcumin on anti-inflammatory and antimicrobial parameters in vitro. Eur J Pharmacol. 2019;859:172486. doi:10.1016/j.ejphar.2019.172486
   PubMed Web of Science ®Google Scholar
• Kumar S, Pandey AK. Chemistry and biological activities of flavonoids: an overview. Sci World J. 2013;2013:162750. doi:10.1155/2013/162750
   Web of Science ®Google Scholar
• Sharma A, Kaur M, Katnoria JK, Nagpal AK. Polyphenols in food: Cancer prevention and apoptosis induction. Curr Med Chem. 2018;25(36):4740–57. doi:10.2174/0929867324666171006144208
   PubMed Web of Science ®Google Scholar
• Menezes JC, Orlikova B, Morceau F, Diederich M. Natural and synthetic flavonoids: structure–activity relationship and chemotherapeutic potential for the treatment of leukemia. Crit Rev Food Sci Nutr . 2016;56(sup1):S4–S28. doi:10.1080/10408398.2015.1074532
   PubMed Web of Science ®Google Scholar
• Kunnumakkara AB, Bordoloi D, Harsha C, Banik K, Gupta SC, Aggarwal BB. Curcumin mediates anticancer effects by modulating multiple cell signaling pathways. Clin Sci. 2017;131(15):1781–99. doi:10.1042/CS20160935
   PubMed Web of Science ®Google Scholar
• Anand P, Kunnumakkara AB, Newman RA, Aggarwal BB. Bioavailability of curcumin: problems and promises. Mol Pharm. 2007;4(6):807–18. doi:10.1021/mp700113r
   PubMed Web of Science ®Google Scholar
• Mu C, Jia P, Yan Z, Liu X, Li X, Liu H. Quercetin induces cell cycle G1 arrest through elevating Cdk inhibitors p21 and p27 in human hepatoma cell line (HepG2)). Methods Find Exp Clin Pharmacol. 2007;29(3):179–84. doi:10.1358/mf.2007.29.3.1092095
   PubMedGoogle Scholar
• Mutlu Altundağ E, Yılmaz AM, Koçtürk S, Taga Y, Yalçın AS. Synergistic induction of apoptosis by quercetin and curcumin in chronic myeloid leukemia (K562) cells. Nutr Cancer. 2018;70(1):97–108. doi:10.1080/01635581.2018.1380208
   PubMed Web of Science ®Google Scholar
• van Ginkel PR, Yan MB, Bhattacharya S, Polans AS, Kenealey JD. Natural products induce a G protein-mediated calcium pathway activating p53 in cancer cells. Toxicol Appl Pharmacol. 2015;288(3):453–62. doi:10.1016/j.taap.2015.08.016
   PubMed Web of Science ®Google Scholar
• Shehzad A, Lee YS. Molecular mechanisms of curcumin action: signal transduction. Biofactors. 2013;39(1):27–36. doi:10.1002/biof.1065
   PubMed Web of Science ®Google Scholar
• Panda AK, Chakraborty D, Sarkar I, Khan T, Sa G. New insights into therapeutic activity and anticancer properties of curcumin. J Exp Pharmacol. 2017;9:31–45. doi:10.2147/JEP.S70568
   PubMedGoogle Scholar
• Shehzad A, Wahid F, Lee YS. Curcumin in cancer chemoprevention: molecular targets, pharmacokinetics, bioavailability, and clinical trials. Arch Pharm (Weinheim). 2010;343(9):489–99. doi:10.1002/ardp.200900319
   PubMed Web of Science ®Google Scholar
• Rafiq S, Raza MH, Younas M, Naeem F, Adeeb R, Iqbal J, Anwar P, Sajid U, Manzoor HM. Molecular targets of curcumin and future therapeutic role in leukemia. JBM. 2018;06(04):33–50. doi:10.4236/jbm.2018.64003
   Google Scholar
• Russo M, Palumbo R, Tedesco I, Mazzarella G, Russo P, Iacomino G, Russo GL. Quercetin and anti-CD95(Fas/Apo1) enhance apoptosis in HPB-ALL cell line. FEBS Lett. 1999;462(3):322–8. doi:10.1016/s0014-5793(99)01544-6
   PubMed Web of Science ®Google Scholar
• Chen F-Y, Cao L-F, Wan H-X, Zhang M-Y, Cai J-Y, Shen L-J, Zhong J-H, Zhong H. Quercetin enhances adriamycin cytotoxicity through induction of apoptosis and regulation of mitogen-activated protein kinase/extracellular signal-regulated kinase/c-Jun N-terminal kinase signaling in multidrug-resistant leukemia K562 cells. Mol Med Rep. 2015;11(1):341–8. doi:10.3892/mmr.2014.2734
   PubMed Web of Science ®Google Scholar
• Mao B, Zhang Z, Wang G. BTG2: a rising star of tumor suppressors (review). Int J Oncol. 2015;46(2):459–64. doi:10.3892/ijo.2014.2765
   PubMed Web of Science ®Google Scholar
• Kawakubo H, Carey JL, Brachtel E, Gupta V, Green JE, Walden PD, Maheswaran S. Expression of the NF-kappaB-responsive gene BTG2 is aberrantly regulated in breast cancer. Oncogene. 2004;23(50):8310–9. doi:10.1038/sj.onc.1208008
   PubMed Web of Science ®Google Scholar
• Otto T, Sicinski P. Cell cycle proteins as promising targets in cancer therapy. Nat Rev Cancer. 2017;17(2):93–115. doi:10.1038/nrc.2016.138
   PubMed Web of Science ®Google Scholar
• Park M-J, Kim E-H, Park I-C, Lee H-C, Woo S-H, Lee J-Y, Hong Y-J, Rhee CH, Choi S-H, Shim B-S, et al. Curcumin inhibits cell cycle progression of immortalized human umbilical vein endothelial (ECV304) cells by up-regulating cyclin-dependent kinase inhibitor, p21WAF1/CIP1, p27KIP1 and p53. Int J Oncol. 2002;21(2):379–83.:
   PubMed Web of Science ®Google Scholar
• Martínez-Castillo M, Villegas-Sepúlveda N, Meraz-Rios MA, Hernández-Zavala A, Berumen J, Coleman MA, Orozco L, Cordova EJ. Curcumin differentially affects cell cycle and cell death in acute and chronic myeloid leukemia cells. Oncol Lett. 2018;15(5):6777–83. doi:10.3892/ol.2018.8112
   PubMed Web of Science ®Google Scholar
• Pulido-Moran M, Moreno-Fernandez J, Ramirez-Tortosa C, Ramirez-Tortosa M. Curcumin and health. Molecules. 2016;21(3):264doi:10.3390/molecules21030264
   PubMed Web of Science ®Google Scholar
• Lee H-P, Li T-M, Tsao J-Y, Fong Y-C, Tang C-H. Curcumin induces cell apoptosis in human chondrosarcoma through extrinsic death receptor pathway. Int Immunopharmacol. 2012;13(2):163–9. doi:10.1016/j.intimp.2012.04.002
   PubMed Web of Science ®Google Scholar
• Zhu G-H, Dai H-P, Shen Q, Ji O, Zhang Q, Zhai Y-L. Curcumin induces apoptosis and suppresses invasion through MAPK and MMP signaling in human monocytic leukemia SHI-1 cells. Pharm Biol. 2016;54(8):1303–11. doi:10.3109/13880209.2015.1060508
   PubMed Web of Science ®Google Scholar
• Fresno Vara JA, Casado E, de Castro J, Cejas P, Belda-Iniesta C, González-Barón M. PI3K/Akt signalling pathway and cancer. Cancer Treat Rev. 2004;30(2):193–204. doi:10.1016/j.ctrv.2003.07.007
   PubMed Web of Science ®Google Scholar
• Blume-Jensen P, Hunter T. Oncogenic kinase signalling. Nature. 2001;411(6835):355–65. doi:10.1038/35077225
   PubMed Web of Science ®Google Scholar
• Chu S, Li L, Singh H, Bhatia R. BCR-tyrosine 177 plays an essential role in Ras and Akt activation and in human hematopoietic progenitor transformation in chronic myelogenous leukemia. Cancer Res. 2007;67(14):7045–53. doi:10.1158/0008-5472.CAN-06-4312
   PubMed Web of Science ®Google Scholar
• Zhang J-Y, Lin M-T, Zhou M-J, Yi T, Tang Y-N, Tang S-L, Yang Z-J, Zhao Z-Z, Chen H-B. Combinational treatment of curcumin and quercetin against gastric cancer MGC-803 cells in vitro. Molecules. 2015;20(6):11524–34. doi:10.3390/molecules200611524
   PubMed Web of Science ®Google Scholar
• Yahfoufi N, Alsadi N, Jambi M, Matar C. The immunomodulatory and anti-inflammatory role of polyphenols. Nutrients. 2018;10(11):1618. doi:10.3390/nu10111618
   PubMed Web of Science ®Google Scholar
• Olivera A, Moore TW, Hu F, Brown AP, Sun A, Liotta DC, Snyder JP, Yoon Y, Shim H, Marcus AI, et al. Inhibition of the NF-κB signaling pathway by the curcumin analog, 3,5-Bis(2-pyridinylmethylidene)-4-piperidone (EF31): anti-inflammatory and anti-cancer properties. Int Immunopharmacol. 2012;12(2):368–77. doi:10.1016/j.intimp.2011.12.009
   PubMed Web of Science ®Google Scholar
• Pfeffer LM. The role of nuclear factor κB in the interferon response. J Interferon Cytokine Res. 2011;31(7):553–9. doi:10.1089/jir.2011.0028
   PubMed Web of Science ®Google Scholar
• Held SAE, Heine A, Kesper AR, Schönberg K, Beckers A, Wolf D, Brossart P. Interferon gamma modulates sensitivity of CML cells to tyrosine kinase inhibitors. Oncoimmunology. 2016;5(1):e1065368. doi:10.1080/2162402X.2015.1065368
   PubMed Web of Science ®Google Scholar
• Bill MA, Bakan C, Benson DM, Fuchs J, Young G, Lesinski GB. Curcumin induces proapoptotic effects against human melanoma cells and modulates the cellular response to immunotherapeutic cytokines. Mol Cancer Ther. 2009;8(9):2726–35. doi:10.1158/1535-7163.MCT-09-0377
   PubMed Web of Science ®Google Scholar
• Kim JH, Gupta SC, Park B, Yadav VR, Aggarwal BB. Turmeric (Curcuma longa) inhibits inflammatory nuclear factor (NF)-κB and NF-κB-regulated gene products and induces death receptors leading to suppressed proliferation, induced chemosensitization, and suppressed osteoclastogenesis. Mol Nutr Food Res. 2012;56(3):454–65. doi:10.1002/mnfr.201100270
   PubMed Web of Science ®Google Scholar